United Insurance Holdings Corp. (UIHC) Forms $19.06 Double Top; Dicerna Pharmaceuticals (DRNA) Shorts Increased By 26.17%

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Logo

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) had an increase of 26.17% in short interest. DRNA’s SI was 1.24 million shares in May as released by FINRA. Its up 26.17% from 980,000 shares previously. With 593,300 avg volume, 2 days are for Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)’s short sellers to cover DRNA’s short positions. The SI to Dicerna Pharmaceuticals Inc’s float is 10.16%. The stock increased 4.26% or $0.52 during the last trading session, reaching $12.73. About 334,870 shares traded. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has risen 274.53% since May 2, 2017 and is uptrending. It has outperformed by 262.98% the S&P500.

United Insurance Holdings Corp. (UIHC) formed double top with $19.63 target or 3.00% above today’s $19.06 share price. United Insurance Holdings Corp. (UIHC) has $814.87M valuation. The stock increased 1.06% or $0.2 during the last trading session, reaching $19.06. About 29,641 shares traded. United Insurance Holdings Corp. (NASDAQ:UIHC) has risen 23.54% since May 2, 2017 and is uptrending. It has outperformed by 11.99% the S&P500.

Investors sentiment increased to 3 in Q4 2017. Its up 2.21, from 0.79 in 2017Q3. It is positive, as 6 investors sold Dicerna Pharmaceuticals, Inc. shares while 5 reduced holdings. 18 funds opened positions while 15 raised stakes. 29.10 million shares or 180.62% more from 10.37 million shares in 2017Q3 were reported. Vanguard Gru holds 0% or 589,573 shares. Bridgeway Capital Mgmt holds 0.01% in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) or 149,900 shares. Jpmorgan Chase & holds 35,423 shares or 0% of its portfolio. Adage Group Limited accumulated 1.98 million shares or 0.04% of the stock. Bridger Management Lc holds 0.54% of its portfolio in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) for 905,998 shares. Panagora Asset Mngmt stated it has 7,533 shares. Renaissance Techs Ltd Liability Company owns 0.01% invested in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) for 560,300 shares. Morgan Stanley reported 1,874 shares or 0% of all its holdings. State Street holds 10,321 shares. 683 Capital Mgmt Llc reported 0.42% of its portfolio in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA). Moreover, California Pub Employees Retirement Sys has 0% invested in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA). Alpine Global Management Limited Liability Corporation has 11,473 shares for 0.02% of their portfolio. Cormorant Asset Management Ltd Liability Com holds 3.66 million shares. Emerald Mutual Fund Advisers Trust invested in 0.2% or 570,861 shares. Eam Invsts Ltd reported 0.08% in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA).

Since December 18, 2017, it had 1 buy, and 2 insider sales for $1.87 million activity. 285,000 shares were bought by Bain Capital Life Sciences Investors – LLC, worth $2.00 million. Weissman James B sold 8,965 shares worth $116,545.

Among 9 analysts covering Dicerna Pharmaceuticals (NASDAQ:DRNA), 4 have Buy rating, 0 Sell and 5 Hold. Therefore 44% are positive. Dicerna Pharmaceuticals had 25 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) earned “Buy” rating by Cowen & Co on Wednesday, August 16. The rating was reinitiated by Leerink Swann with “Mkt Perform” on Tuesday, January 31. The firm has “Buy” rating given on Thursday, November 2 by Stifel Nicolaus. The firm earned “Hold” rating on Friday, August 11 by Chardan Capital Markets. The firm has “Buy” rating by Stifel Nicolaus given on Friday, March 9. As per Tuesday, September 8, the company rating was initiated by Cowen & Co. Stifel Nicolaus maintained it with “Buy” rating and $16 target in Tuesday, May 10 report. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has “Neutral” rating given on Monday, August 15 by Chardan Capital Markets. H.C. Wainwright maintained Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) rating on Friday, August 11. H.C. Wainwright has “Buy” rating and $600 target. The stock has “Buy” rating by Stifel Nicolaus on Thursday, June 30.

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiovascular, and viral infectious diseases in the United States and internationally. The company has market cap of $659.38 million. The companyÂ’s preclinical stage development programs include DCR-PHXC for the treatment of primary hyperoxaluria type 1; DCR-PCSK9, which targets the PCSK9 gene in the treatment of statin-refractory patients with hypercholesterolemia; and DCR-HBV for the treatment of chronic hepatitis B virus infection, as well as other product candidates for use in the treatment of cardiovascular and chronic liver diseases. It currently has negative earnings. It has a research collaboration and license agreements with Kyowa Hakko Kirin Co., Ltd.; City of Hope, an academic research and medical center; and Plant Bioscience Limited.

Investors sentiment decreased to 1.07 in Q4 2017. Its down 0.18, from 1.25 in 2017Q3. It fall, as 11 investors sold United Insurance Holdings Corp. shares while 33 reduced holdings. 12 funds opened positions while 35 raised stakes. 13.51 million shares or 2.54% more from 13.17 million shares in 2017Q3 were reported. California Employees Retirement System invested in 0% or 31,900 shares. 8 were reported by Assetmark Inc. Brandywine Glob Mgmt Ltd has 0% invested in United Insurance Holdings Corp. (NASDAQ:UIHC) for 19,812 shares. State Of Alaska Department Of Revenue invested in 0% or 4,066 shares. Prudential Financial Inc owns 32,720 shares. Franklin Resource has invested 0.01% in United Insurance Holdings Corp. (NASDAQ:UIHC). Globeflex Capital Limited Partnership reported 5,833 shares stake. Buckhead Limited Liability Company stated it has 0.07% of its portfolio in United Insurance Holdings Corp. (NASDAQ:UIHC). Barclays Public Ltd Liability holds 0% or 4,829 shares. Quinn Opportunity Prtn Limited Liability reported 14,421 shares. Citigroup accumulated 4,862 shares. Ls Advisors Lc has invested 0% in United Insurance Holdings Corp. (NASDAQ:UIHC). Guggenheim Capital Ltd Llc holds 111,664 shares. 26,736 are held by Parametric Port Associates. Blackrock owns 2.68 million shares for 0% of their portfolio.

Since December 15, 2017, it had 2 insider buys, and 0 sales for $41,661 activity. Shares for $16,596 were bought by Maroney Patrick. POITEVINT ALEC II also bought $25,065 worth of United Insurance Holdings Corp. (NASDAQ:UIHC) on Friday, December 15.

United Insurance Holdings Corp. (NASDAQ:UIHC) Institutional Positions Chart